Kobe, Japan

Tetsu Kawano

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Hyogo, JP (2010 - 2015)
  • Kobe, JP (2015 - 2017)

Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Tetsu Kawano: A Pioneer in Antibody Development

Introduction: Tetsu Kawano, an innovative inventor residing in Kobe, Japan, has made significant contributions to the field of biomedicine. With a total of six patents to his name, his works are at the forefront of therapeutic advancements, particularly in the realm of monoclonal antibodies.

Latest Patents: Among Tetsu Kawano's latest patents are the developments of anti-CCL20 antibodies and anti-human XCR1 antibodies. The anti-CCL20 antibodies focus on novel humanized, chimeric, and murine antibodies that specifically bind to the human CC chemokine ligand 20 (CCL20). These innovations include methods for creating heavy chains and light chains of the antibodies, as well as isolated nucleic acids, recombinant vectors, and host cells that encode components of these antibodies. This invention holds promising therapeutic potential for treating inflammatory and autoimmune disorders, as well as cancer. Similarly, the anti-human XCR1 antibodies are designed to bind to specific epitopes, enhancing the capabilities of targeted therapies.

Career Highlights: Tetsu Kawano has worked at Eisai R&D Management Co., Ltd., a prominent player in the pharmaceutical industry known for its commitment to research and development. His dedication and innovative mindset have solidified his position as a key contributor to advancements in medical science.

Collaborations: Throughout his career, Tetsu has collaborated with colleagues such as Toshio Imai and Yoshimasa Sakamoto. These collaborations have undoubtedly enriched his research and expanded the horizons of his projects, leading to impactful inventions in the medical field.

Conclusion: Tetsu Kawano stands out as a pioneering inventor whose work has the potential to revolutionize treatment methodologies in healthcare. With his impressive portfolio of patents and collaborations, he continues to influence the landscape of immunotherapy and reinforce the importance of innovation in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…